Literature DB >> 25008151

Real time evaluation of overranging in helical computed tomography.

Diego Trevisan1, Faustino Bonutti2, Daniele Ravanelli3, Aldo Valentini4.   

Abstract

Overranging or overscanning increases the dose delivered to patients undergoing helical Computed Tomography examinations. In order to reduce it, nowadays most of the multidetector tomographs close the X-ray beam aperture at the scan extremes. This technical innovation, usually referred to as dynamic or adaptive collimation, also influences the overranging assessment methods. In particular, the film free approach proposed in previous studies is not suitable for these modern tomographs. The present study aims to introduce a new method of estimating overranging with real time dosimetry, even suitable for tomographs equipped with adaptive collimation. The approach proposed is very easy to implement and time saving because only a pencil chamber is required. It is also equivalent in precision and in accuracy to the film based one, considered an absolute benchmark.
Copyright © 2014 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Computed tomography; Overranging; Overscanning

Mesh:

Year:  2014        PMID: 25008151     DOI: 10.1016/j.ejmp.2014.06.041

Source DB:  PubMed          Journal:  Phys Med        ISSN: 1120-1797            Impact factor:   2.685


  2 in total

1.  Evaluation of an adaptive detector collimation for prospectively ECG-triggered coronary CT angiography with third-generation dual-source CT.

Authors:  Michael Messerli; Patricia Dewes; Jan-Erik Scholtz; Christophe Arendt; Simon Wildermuth; Thomas J Vogl; Ralf W Bauer
Journal:  Eur Radiol       Date:  2017-12-07       Impact factor: 5.315

2.  Efficacy of a dynamic collimator for overranging dose reduction in a second- and third-generation dual source CT scanner.

Authors:  Ronald Booij; Marcel L Dijkshoorn; Marcel van Straten
Journal:  Eur Radiol       Date:  2017-01-26       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.